Reappraisal of the Immunophenotype of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs)—Gastric Pyloric and Small Intestinal Immunophenotype Expression in Gastric and Intestinal Type IPMNs—

1 Adsay, N. V., Merati, K., Basturk, O., Iacobuzio-Donahue, C., Levi, E., Cheng, J. D., Sarkar, F. H., Hruban, R. H. and Klimstra, D. S. (2004) Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an “intestinal” pathway of carcinogenesis in the pancreas. Am. J. Surg. Pathol. 28; 839–848.

2 Adsay, N. V., Fukushima, N., Furukawa, T., Hruban, R. H., Klimstra, D. S., Klöppel, G., Offerhaus, G. J. A., Pitman, M. B., Shimizu, M. and Zamboni, G. (2010) Intraductal neoplasms of the pancreas. In “WHO Classification of Tumours of the Digestive System”, 4th ed., ed. by F. T. Bosman, F. Carneiro, R. H. Hruban and N. D. Theise, IARC, Lyon, pp. 304–313.

3 Andrejevic-Blant, S., Kosmahl, M., Sipos, B. and Kloppel, G. (2007) Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity. Virchows Arch. 451; 863–869.

4 Bai, Y. Q., Yamamoto, H., Akiyama, Y., Tanaka, H., Takizawa, T., Koike, M., Kenji Yagi, O., Saitoh, K., Takeshita, K., Iwai, T. and Yuasa, Y. (2002) Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett. 176; 47–55.

5 Ban, S., Naitoh, Y., Mino-Kenudson, M., Sakurai, T., Kuroda, M., Koyama, I., Lauwers, G. Y. and Shimizu, M. (2006) Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am. J. Surg. Pathol. 30; 1561–1569.

6 Buisine, M. P., Devisme, L., Maunoury, V., Deschodt, E., Gosselin, B., Copin, M. C., Aubert, J. P. and Porchet, N. (2000) Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. I. Stomach. A relationship to gastric carcinoma. J. Histochem. Cytochem. 48; 1657–1666.

7 Butler, S. L., Dong, H., Cardona, D., Jia, M., Zheng, R., Zhu, H., Crawford, J. M. and Liu, C. (2008) The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. Lab. Invest. 88; 78–88.

8 Chu, P. G., Jiang, Z. and Weiss, L. M. (2003) Hepatocyte antigen as a marker of intestinal metaplasia. Am. J. Surg. Pathol. 27; 952–959.

9 Eda, A., Osawa, H., Yanaka, I., Satoh, K., Mutoh, H., Kihira, K. and Sugano, K. (2002) Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J. Gastroenterol. 37; 94–100.

10 Furukawa, T., Kloppel, G., Volkan Adsay, N., Albores-Saavedra, J., Fukushima, N., Horii, A., Hruban, R. H., Kato, Y., Klimstra, D. S., Longnecker, D. S., Luttges, J., Offerhaus, G. J., Shimizu, M., Sunamura, M., Suriawinata, A., Takaori, K. and Yonezawa, S. (2005) Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 447; 794–799.

11 Gannon, M., Gamer, L. W. and Wright, C. V. (2001) Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdx1. Dev. Biol. 238; 185–201.

12 Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., Kawaguchi, Y., Johann, D., Liotta, L. A., Crawford, H. C., Putt, M. E., Jacks, T., Wright, C. V., Hruban, R. H., Lowy, A. M. and Tuveson, D. A. (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 4; 437–450.

13 Horinouchi, M., Nagata, K., Nakamura, A., Goto, M., Takao, S., Sakamoto, M., Fukushima, N., Miwa, A., Irimura, T., Imai, K., Sato, E. and Yonezawa, S. (2003) Expression of different glycoforms of membrane mucin (MUC1) and secretory mucin (MUC2, MUC5AC and MUC6) in pancreatic neoplasms. Acta Histochem. Cytochem. 36; 443–453.

14 Hruban, R. H., Takaori, K., Klimstra, D. S., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., Biankin, S. A., Compton, C., Fukushima, N., Furukawa, T., Goggins, M., Kato, Y., Kloppel, G., Longnecker, D. S., Luttges, J., Maitra, A., Offerhaus, G. J., Shimizu, M. and Yonezawa, S. (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am. J. Surg. Pathol. 28; 977–987.

15 Ishihara, K., Kurihara, M., Goso, Y., Ota, H., Katsuyama, T. and Hotta, K. (1996) Establishment of monoclonal antibodies against carbohydrate moiety of gastric mucins distributed in the different sites and layers of rat gastric mucosa. Glycoconj. J. 13; 857–864.

16 Kaneko, Y., Nakamura, T., Hayama, M., Hosaka, N., Akamatsu, T. and Ota, H. (2008) Altered expression of CDX-2, PDX-1 and mucin core proteins in “Ulcer-associated cell lineage (UACL)” in Crohn’s disease. J. Mol. Histol. 39; 161–168.

17 Katsuyama, T. and Spicer, S. S. (1978) Histochemical differentiation of complex carbohydrates with variants of the concanavalin A-horseradish peroxidase method. J. Histochem. Cytochem. 26; 233–250.

18 Lugli, A., Tornillo, L., Mirlacher, M., Bundi, M., Sauter, G. and Terracciano, L. M. (2004) Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples. Am. J. Clin. Pathol. 122; 721–727.

19 Magnusson, K., de Wit, M., Brennan, D. J., Johnson, L. B., McGee, S. F., Lundberg, E., Naicker, K., Klinger, R., Kampf, C., Asplund, A., Wester, K., Gry, M., Bjartell, A., Gallagher, W. M., Rexhepaj, E., Kilpinen, S., Kallioniemi, O. P., Belt, E., Goos, J., Meijer, G., Birgisson, H., Glimelius, B., Borrebaeck, C. A., Navani, S., Uhlen, M., O’Connor, D. P., Jirstrom, K. and Ponten, F. (2011) SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am. J. Surg. Pathol. 35; 937–948.

20 Matsuzawa, K., Akamatsu, T. and Katsuyama, T. (1992) Mucin histochemistry of pancreatic duct cell carcinoma, with special reference to organoid differentiation simulating gastric pyloric mucosa. Hum. Pathol. 23; 925–933.

21 Mochizuka, A., Uehara, T., Nakamura, T., Kobayashi, Y. and Ota, H. (2007) Hyperplastic polyps and sessile serrated ‘adenomas’ of the colon and rectum display gastric pyloric differentiation. Histochem. Cell Biol. 128; 445–455.

22 Mohri, D., Asaoka, Y., Ijichi, H., Miyabayashi, K., Kudo, Y., Seto, M., Ohta, M., Tada, M., Tanaka, Y., Ikenoue, T., Tateishi, K., Isayama, H., Kanai, F., Fukushima, N., Kawabe, T., Omata, M. and Koike, K. (2012) Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression. J. Gastroenterol. 47; 203–213.

23 Moniaux, N., Escande, F., Porchet, N., Aubert, J. P. and Batra, S. K. (2001) Structural organization and classification of the human mucin genes. Front. Biosci. 6; D1192–1206.

24 Nagata, K., Horinouchi, M., Saitou, M., Higashi, M., Nomoto, M., Goto, M. and Yonezawa, S. (2007) Mucin expression profile in pancreatic cancer and the precursor lesions. J. Hepatobiliary. Pancreat. Surg. 14; 243–254.

25 Nakajima, K., Ota, H., Zhang, M. X., Sano, K., Honda, T., Ishii, K. and Nakayama, J. (2003) Expression of gastric gland mucous cell-type mucin in normal and neoplastic human tissues. J. Histochem. Cytochem. 51; 1689–1698.

26 Nakamura, A., Horinouchi, M., Goto, M., Nagata, K., Sakoda, K., Takao, S., Imai, K., Kim, Y. S., Sato, E. and Yonezawa, S. (2002) New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J. Pathol. 197; 201–210.

27 Nomura, S., Settle, S. H., Leys, C. M., Means, A. L., Peek, R. M. Jr., Leach, S. D., Wright, C. V., Coffey, R. J. and Goldenring, J. R. (2005) Evidence for repatterning of the gastric fundic epithelium associated with Menetrier’s disease and TGFalpha overexpression. Gastroenterology 128; 1292–1305.

28 Offield, M. F., Jetton, T. L., Labosky, P. A., Ray, M., Stein, R. W., Magnuson, M. A., Hogan, B. L. and Wright, C. V. (1996) PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122; 983–995.

29 Ota, H., Langston, C., Honda, T., Katsuyama, T. and Genta, R. M. (1998) Histochemical analysis of mucous cells of congenital adenomatoid malformation of the lung: insights into the carcinogenesis of pulmonary adenocarcinoma expressing gastric mucins. Am. J. Clin. Pathol. 110; 450–455.

30 Ota, H., Hayama, M., Nakayama, J., Hidaka, H., Honda, T., Ishii, K., Fukushima, M., Uehara, T., Kurihara, M., Ishihara, K., Hotta, K. and Katsuyama, T. (2001) Cell lineage specificity of newly raised monoclonal antibodies against gastric mucins in normal, metaplastic, and neoplastic human tissues and their application to pathology diagnosis. Am. J. Clin. Pathol. 115; 69–79.

31 Ota, H., Harada, O., Uehara, T., Hayama, M. and Ishii, K. (2011) Aberrant expression of TFF1, TFF2, and PDX1 and their diagnostic value in lobular endocervical glandular hyperplasia. Am. J. Clin. Pathol. 135; 253–261.

32 Park, J. Y., Hong, S. M., Klimstra, D. S., Goggins, M. G., Maitra, A. and Hruban, R. H. (2011) Pdx1 expression in pancreatic precursor lesions and neoplasms. Appl. Immunohistochem. Mol. Morphol. 19; 444–449.

33 Sakai, H., Eishi, Y., Li, X. L., Akiyama, Y., Miyake, S., Takizawa, T., Konishi, N., Tatematsu, M., Koike, M. and Yuasa, Y. (2004) PDX1 homeobox protein expression in pseudopyloric glands and gastric carcinomas. Gut 53; 323–330.

34 Sanada, Y., Kunita, S. and Yoshida, K. (2008) Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas. Oncol. Rep. 19; 1435–1443.

35 Sessa, F., Bonato, M., Frigerio, B., Capella, C., Solcia, E., Prat, M., Bara, J. and Samloff, I. M. (1990) Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells. Gastroenterology 98; 1655–1665.

36 Shi, C. and Hruban, R. H. (2012) Intraductal papillary mucinous neoplasm. Hum. Pathol. 43; 1–16.

37 Stoffers, D. A., Heller, R. S., Miller, C. P. and Habener, J. F. (1999) Developmental expression of the homeodomain protein IDX-1 in mice transgenic for an IDX-1 promoter/lacZ transcriptional reporter. Endocrinology 140; 5374–5381.

38 Szemes, M., Gyorgy, A., Paweletz, C., Dobi, A. and Agoston, D. V. (2006) Isolation and characterization of SATB2, a novel AT-rich DNA binding protein expressed in development- and cell-specific manner in the rat brain. Neurochem. Res. 31; 237–246.

39 Tanaka, M., Fernandez-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J. Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., Shimizu, M., Wolfgang, C. L., Yamaguchi, K. and Yamao, K. (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12; 183–197.

40 Wennerberg, A. E., Nalesnik, M. A. and Coleman, W. B. (1993) Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am. J. Pathol. 143; 1050–1054.

41 Yamada, N., Hamada, T., Goto, M., Tsutsumida, H., Higashi, M., Nomoto, M. and Yonezawa, S. (2006) MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. Int. J. Cancer 119; 1850–1857.

42 Yonezawa, S., Nakamura, A., Horinouchi, M. and Sato, E. (2002) The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J. Hepatobiliary. Pancreat. Surg. 9; 328–341.

43 Yonezawa, S., Higashi, M., Yamada, N. and Goto, M. (2008) Precursor lesions of pancreatic cancer. Gut Liver 2; 137–154.

44 Zhang, M. X., Nakayama, J., Hidaka, E., Kubota, S., Yan, J., Ota, H. and Fukuda, M. (2001) Immunohistochemical demonstration of alpha1,4-N-acetylglucosaminyltransferase that forms GlcNAcalpha1,4Galbeta residues in human gastrointestinal mucosa. J. Histochem. Cytochem. 49; 587–596.